nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ORM1—Vismodegib—skin cancer	0.22	0.245	CbGbCtD
Alfentanil—ORM1—Vemurafenib—skin cancer	0.174	0.194	CbGbCtD
Alfentanil—ALB—Vismodegib—skin cancer	0.0924	0.103	CbGbCtD
Alfentanil—ALB—Vemurafenib—skin cancer	0.073	0.0816	CbGbCtD
Alfentanil—ABCB1—Vismodegib—skin cancer	0.0483	0.054	CbGbCtD
Alfentanil—CYP3A4—Imiquimod—skin cancer	0.0418	0.0467	CbGbCtD
Alfentanil—CYP3A4—Temozolomide—skin cancer	0.0418	0.0467	CbGbCtD
Alfentanil—ALB—Fluorouracil—skin cancer	0.0328	0.0366	CbGbCtD
Alfentanil—CYP3A4—Vismodegib—skin cancer	0.0289	0.0323	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—skin cancer	0.0268	0.03	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0268	0.03	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—skin cancer	0.0254	0.0284	CbGbCtD
Alfentanil—CYP3A4—Vemurafenib—skin cancer	0.0229	0.0256	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—skin cancer	0.0201	0.0225	CbGbCtD
Alfentanil—ABCB1—Docetaxel—skin cancer	0.0131	0.0146	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—skin cancer	0.00785	0.00877	CbGbCtD
Alfentanil—Procedural pain—Imiquimod—skin cancer	0.0061	0.0582	CcSEcCtD
Alfentanil—Connective tissue disorder—Vismodegib—skin cancer	0.00163	0.0156	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00122	0.0117	CcSEcCtD
Alfentanil—Nervous system disorder—Vismodegib—skin cancer	0.00116	0.0111	CcSEcCtD
Alfentanil—Skin disorder—Vismodegib—skin cancer	0.00115	0.0109	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vismodegib—skin cancer	0.00102	0.00973	CcSEcCtD
Alfentanil—Fatigue—Vismodegib—skin cancer	0.00102	0.00972	CcSEcCtD
Alfentanil—Pain—Vismodegib—skin cancer	0.00101	0.00964	CcSEcCtD
Alfentanil—Connective tissue disorder—Vemurafenib—skin cancer	0.00101	0.00963	CcSEcCtD
Alfentanil—Disorientation—Bleomycin—skin cancer	0.00101	0.00959	CcSEcCtD
Alfentanil—Eye disorder—Vemurafenib—skin cancer	0.000959	0.00916	CcSEcCtD
Alfentanil—Cardiac disorder—Vemurafenib—skin cancer	0.000953	0.00909	CcSEcCtD
Alfentanil—Dermatitis atopic—Docetaxel—skin cancer	0.000939	0.00896	CcSEcCtD
Alfentanil—Angiopathy—Vemurafenib—skin cancer	0.000931	0.00889	CcSEcCtD
Alfentanil—Mediastinal disorder—Vemurafenib—skin cancer	0.000925	0.00883	CcSEcCtD
Alfentanil—Chills—Vemurafenib—skin cancer	0.000921	0.00879	CcSEcCtD
Alfentanil—Erythema—Vemurafenib—skin cancer	0.000894	0.00853	CcSEcCtD
Alfentanil—Connective tissue disorder—Imiquimod—skin cancer	0.00086	0.00821	CcSEcCtD
Alfentanil—Asthenia—Vismodegib—skin cancer	0.000847	0.00809	CcSEcCtD
Alfentanil—Visual impairment—Imiquimod—skin cancer	0.000844	0.00805	CcSEcCtD
Alfentanil—Pruritus—Vismodegib—skin cancer	0.000835	0.00797	CcSEcCtD
Alfentanil—Euphoric mood—Fluorouracil—skin cancer	0.000827	0.00789	CcSEcCtD
Alfentanil—Eye disorder—Imiquimod—skin cancer	0.000818	0.00781	CcSEcCtD
Alfentanil—Angiopathy—Imiquimod—skin cancer	0.000794	0.00758	CcSEcCtD
Alfentanil—Immune system disorder—Imiquimod—skin cancer	0.000791	0.00755	CcSEcCtD
Alfentanil—Mediastinal disorder—Imiquimod—skin cancer	0.000789	0.00753	CcSEcCtD
Alfentanil—Chills—Imiquimod—skin cancer	0.000786	0.0075	CcSEcCtD
Alfentanil—Arrhythmia—Imiquimod—skin cancer	0.000782	0.00747	CcSEcCtD
Alfentanil—Disorientation—Fluorouracil—skin cancer	0.000781	0.00746	CcSEcCtD
Alfentanil—Cough—Vemurafenib—skin cancer	0.00078	0.00744	CcSEcCtD
Alfentanil—Mental disorder—Imiquimod—skin cancer	0.000767	0.00732	CcSEcCtD
Alfentanil—Bronchospasm—Bleomycin—skin cancer	0.000764	0.0073	CcSEcCtD
Alfentanil—Erythema—Imiquimod—skin cancer	0.000762	0.00727	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000756	0.00721	CcSEcCtD
Alfentanil—Vomiting—Vismodegib—skin cancer	0.000751	0.00716	CcSEcCtD
Alfentanil—Rash—Vismodegib—skin cancer	0.000744	0.00711	CcSEcCtD
Alfentanil—Dermatitis—Vismodegib—skin cancer	0.000744	0.0071	CcSEcCtD
Alfentanil—Anaphylactic shock—Vemurafenib—skin cancer	0.000729	0.00696	CcSEcCtD
Alfentanil—Nervous system disorder—Vemurafenib—skin cancer	0.000715	0.00683	CcSEcCtD
Alfentanil—Skin disorder—Vemurafenib—skin cancer	0.000708	0.00676	CcSEcCtD
Alfentanil—Nausea—Vismodegib—skin cancer	0.000701	0.00669	CcSEcCtD
Alfentanil—Agitation—Imiquimod—skin cancer	0.0007	0.00669	CcSEcCtD
Alfentanil—Blood pressure increased—Docetaxel—skin cancer	0.000695	0.00663	CcSEcCtD
Alfentanil—Hypotension—Vemurafenib—skin cancer	0.000682	0.00651	CcSEcCtD
Alfentanil—Loss of consciousness—Imiquimod—skin cancer	0.00067	0.00639	CcSEcCtD
Alfentanil—Cough—Imiquimod—skin cancer	0.000665	0.00635	CcSEcCtD
Alfentanil—Cardiac arrest—Fluorouracil—skin cancer	0.000664	0.00634	CcSEcCtD
Alfentanil—Convulsion—Imiquimod—skin cancer	0.00066	0.0063	CcSEcCtD
Alfentanil—Hypertension—Imiquimod—skin cancer	0.000658	0.00628	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000644	0.00615	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00063	0.00601	CcSEcCtD
Alfentanil—Fatigue—Vemurafenib—skin cancer	0.000629	0.006	CcSEcCtD
Alfentanil—Nervous system disorder—Imiquimod—skin cancer	0.00061	0.00582	CcSEcCtD
Alfentanil—Tachycardia—Imiquimod—skin cancer	0.000607	0.00579	CcSEcCtD
Alfentanil—Skin disorder—Imiquimod—skin cancer	0.000604	0.00577	CcSEcCtD
Alfentanil—Hyperhidrosis—Imiquimod—skin cancer	0.000601	0.00574	CcSEcCtD
Alfentanil—Body temperature increased—Vemurafenib—skin cancer	0.000577	0.0055	CcSEcCtD
Alfentanil—Chills—Bleomycin—skin cancer	0.000558	0.00533	CcSEcCtD
Alfentanil—Somnolence—Imiquimod—skin cancer	0.000553	0.00528	CcSEcCtD
Alfentanil—Erythema—Bleomycin—skin cancer	0.000541	0.00517	CcSEcCtD
Alfentanil—Hypersensitivity—Vemurafenib—skin cancer	0.000537	0.00513	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Imiquimod—skin cancer	0.000537	0.00513	CcSEcCtD
Alfentanil—Fatigue—Imiquimod—skin cancer	0.000536	0.00512	CcSEcCtD
Alfentanil—Visual disturbance—Docetaxel—skin cancer	0.000532	0.00508	CcSEcCtD
Alfentanil—Pain—Imiquimod—skin cancer	0.000532	0.00508	CcSEcCtD
Alfentanil—Asthenia—Vemurafenib—skin cancer	0.000523	0.00499	CcSEcCtD
Alfentanil—Chills—Dactinomycin—skin cancer	0.000521	0.00497	CcSEcCtD
Alfentanil—Pruritus—Vemurafenib—skin cancer	0.000516	0.00493	CcSEcCtD
Alfentanil—Connective tissue disorder—Temozolomide—skin cancer	0.000516	0.00492	CcSEcCtD
Alfentanil—Feeling abnormal—Imiquimod—skin cancer	0.000513	0.00489	CcSEcCtD
Alfentanil—Epistaxis—Fluorouracil—skin cancer	0.000508	0.00485	CcSEcCtD
Alfentanil—Visual impairment—Temozolomide—skin cancer	0.000506	0.00483	CcSEcCtD
Alfentanil—Erythema—Dactinomycin—skin cancer	0.000505	0.00482	CcSEcCtD
Alfentanil—Urticaria—Imiquimod—skin cancer	0.000494	0.00472	CcSEcCtD
Alfentanil—Body temperature increased—Imiquimod—skin cancer	0.000492	0.00469	CcSEcCtD
Alfentanil—Eye disorder—Temozolomide—skin cancer	0.00049	0.00468	CcSEcCtD
Alfentanil—Cardiac disorder—Temozolomide—skin cancer	0.000487	0.00465	CcSEcCtD
Alfentanil—Dizziness—Vemurafenib—skin cancer	0.000482	0.0046	CcSEcCtD
Alfentanil—Angiopathy—Temozolomide—skin cancer	0.000476	0.00454	CcSEcCtD
Alfentanil—Immune system disorder—Temozolomide—skin cancer	0.000474	0.00452	CcSEcCtD
Alfentanil—Mediastinal disorder—Temozolomide—skin cancer	0.000473	0.00451	CcSEcCtD
Alfentanil—Cough—Bleomycin—skin cancer	0.000472	0.00451	CcSEcCtD
Alfentanil—Chills—Temozolomide—skin cancer	0.000471	0.00449	CcSEcCtD
Alfentanil—Vomiting—Vemurafenib—skin cancer	0.000464	0.00443	CcSEcCtD
Alfentanil—Rash—Vemurafenib—skin cancer	0.00046	0.00439	CcSEcCtD
Alfentanil—Mental disorder—Temozolomide—skin cancer	0.00046	0.00439	CcSEcCtD
Alfentanil—Dermatitis—Vemurafenib—skin cancer	0.000459	0.00439	CcSEcCtD
Alfentanil—Hypersensitivity—Imiquimod—skin cancer	0.000458	0.00437	CcSEcCtD
Alfentanil—Headache—Vemurafenib—skin cancer	0.000457	0.00436	CcSEcCtD
Alfentanil—Erythema—Temozolomide—skin cancer	0.000457	0.00436	CcSEcCtD
Alfentanil—Asthenia—Imiquimod—skin cancer	0.000446	0.00426	CcSEcCtD
Alfentanil—Confusional state—Bleomycin—skin cancer	0.000446	0.00425	CcSEcCtD
Alfentanil—Anaphylactic shock—Bleomycin—skin cancer	0.000442	0.00422	CcSEcCtD
Alfentanil—Pruritus—Imiquimod—skin cancer	0.00044	0.0042	CcSEcCtD
Alfentanil—Nausea—Vemurafenib—skin cancer	0.000433	0.00414	CcSEcCtD
Alfentanil—Arrhythmia—Fluorouracil—skin cancer	0.000432	0.00412	CcSEcCtD
Alfentanil—Vision blurred—Temozolomide—skin cancer	0.00043	0.00411	CcSEcCtD
Alfentanil—Bronchospasm—Docetaxel—skin cancer	0.000429	0.00409	CcSEcCtD
Alfentanil—Erythema—Fluorouracil—skin cancer	0.000421	0.00402	CcSEcCtD
Alfentanil—Agitation—Temozolomide—skin cancer	0.00042	0.00401	CcSEcCtD
Alfentanil—Hypotension—Bleomycin—skin cancer	0.000413	0.00394	CcSEcCtD
Alfentanil—Dizziness—Imiquimod—skin cancer	0.000411	0.00393	CcSEcCtD
Alfentanil—Cough—Temozolomide—skin cancer	0.000399	0.0038	CcSEcCtD
Alfentanil—Vision blurred—Fluorouracil—skin cancer	0.000397	0.00379	CcSEcCtD
Alfentanil—Convulsion—Temozolomide—skin cancer	0.000396	0.00378	CcSEcCtD
Alfentanil—Vomiting—Imiquimod—skin cancer	0.000396	0.00377	CcSEcCtD
Alfentanil—Hypertension—Temozolomide—skin cancer	0.000394	0.00376	CcSEcCtD
Alfentanil—Rash—Imiquimod—skin cancer	0.000392	0.00374	CcSEcCtD
Alfentanil—Dermatitis—Imiquimod—skin cancer	0.000392	0.00374	CcSEcCtD
Alfentanil—Headache—Imiquimod—skin cancer	0.00039	0.00372	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000386	0.00369	CcSEcCtD
Alfentanil—Pain—Bleomycin—skin cancer	0.000378	0.00361	CcSEcCtD
Alfentanil—Confusional state—Temozolomide—skin cancer	0.000376	0.00359	CcSEcCtD
Alfentanil—Anaphylactic shock—Temozolomide—skin cancer	0.000373	0.00356	CcSEcCtD
Alfentanil—Nausea—Imiquimod—skin cancer	0.000369	0.00353	CcSEcCtD
Alfentanil—Epistaxis—Docetaxel—skin cancer	0.000367	0.0035	CcSEcCtD
Alfentanil—Nervous system disorder—Temozolomide—skin cancer	0.000366	0.00349	CcSEcCtD
Alfentanil—Convulsion—Fluorouracil—skin cancer	0.000365	0.00348	CcSEcCtD
Alfentanil—Feeling abnormal—Bleomycin—skin cancer	0.000364	0.00348	CcSEcCtD
Alfentanil—Skin disorder—Temozolomide—skin cancer	0.000362	0.00346	CcSEcCtD
Alfentanil—Hyperhidrosis—Temozolomide—skin cancer	0.00036	0.00344	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—skin cancer	0.000355	0.00339	CcSEcCtD
Alfentanil—Pain—Dactinomycin—skin cancer	0.000352	0.00336	CcSEcCtD
Alfentanil—Urticaria—Bleomycin—skin cancer	0.000351	0.00335	CcSEcCtD
Alfentanil—Body temperature increased—Bleomycin—skin cancer	0.000349	0.00333	CcSEcCtD
Alfentanil—Confusional state—Fluorouracil—skin cancer	0.000346	0.00331	CcSEcCtD
Alfentanil—Anaphylactic shock—Fluorouracil—skin cancer	0.000343	0.00328	CcSEcCtD
Alfentanil—Connective tissue disorder—Docetaxel—skin cancer	0.000343	0.00327	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—skin cancer	0.00034	0.00324	CcSEcCtD
Alfentanil—Nervous system disorder—Fluorouracil—skin cancer	0.000337	0.00321	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—skin cancer	0.000336	0.00321	CcSEcCtD
Alfentanil—Tachycardia—Fluorouracil—skin cancer	0.000335	0.0032	CcSEcCtD
Alfentanil—Somnolence—Temozolomide—skin cancer	0.000331	0.00316	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—skin cancer	0.000326	0.00311	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—skin cancer	0.000326	0.00311	CcSEcCtD
Alfentanil—Hypersensitivity—Bleomycin—skin cancer	0.000326	0.00311	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—skin cancer	0.000324	0.00309	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Temozolomide—skin cancer	0.000322	0.00307	CcSEcCtD
Alfentanil—Fatigue—Temozolomide—skin cancer	0.000321	0.00307	CcSEcCtD
Alfentanil—Hypotension—Fluorouracil—skin cancer	0.000321	0.00306	CcSEcCtD
Alfentanil—Pain—Temozolomide—skin cancer	0.000319	0.00304	CcSEcCtD
Alfentanil—Asthenia—Bleomycin—skin cancer	0.000317	0.00303	CcSEcCtD
Alfentanil—Angiopathy—Docetaxel—skin cancer	0.000317	0.00302	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—skin cancer	0.000315	0.00301	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—skin cancer	0.000314	0.003	CcSEcCtD
Alfentanil—Chills—Docetaxel—skin cancer	0.000313	0.00299	CcSEcCtD
Alfentanil—Pruritus—Bleomycin—skin cancer	0.000313	0.00298	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—skin cancer	0.000312	0.00298	CcSEcCtD
Alfentanil—Feeling abnormal—Temozolomide—skin cancer	0.000307	0.00293	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—skin cancer	0.000306	0.00292	CcSEcCtD
Alfentanil—Somnolence—Fluorouracil—skin cancer	0.000305	0.00291	CcSEcCtD
Alfentanil—Erythema—Docetaxel—skin cancer	0.000304	0.0029	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—skin cancer	0.000304	0.0029	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000297	0.00283	CcSEcCtD
Alfentanil—Urticaria—Temozolomide—skin cancer	0.000296	0.00283	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—skin cancer	0.000296	0.00282	CcSEcCtD
Alfentanil—Body temperature increased—Temozolomide—skin cancer	0.000295	0.00281	CcSEcCtD
Alfentanil—Pain—Fluorouracil—skin cancer	0.000294	0.0028	CcSEcCtD
Alfentanil—Feeling abnormal—Fluorouracil—skin cancer	0.000283	0.0027	CcSEcCtD
Alfentanil—Vomiting—Bleomycin—skin cancer	0.000281	0.00268	CcSEcCtD
Alfentanil—Rash—Bleomycin—skin cancer	0.000279	0.00266	CcSEcCtD
Alfentanil—Dermatitis—Bleomycin—skin cancer	0.000278	0.00266	CcSEcCtD
Alfentanil—Hypersensitivity—Temozolomide—skin cancer	0.000275	0.00262	CcSEcCtD
Alfentanil—Urticaria—Fluorouracil—skin cancer	0.000273	0.0026	CcSEcCtD
Alfentanil—Body temperature increased—Fluorouracil—skin cancer	0.000272	0.00259	CcSEcCtD
Alfentanil—Asthenia—Temozolomide—skin cancer	0.000267	0.00255	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—skin cancer	0.000267	0.00255	CcSEcCtD
Alfentanil—Cough—Docetaxel—skin cancer	0.000265	0.00253	CcSEcCtD
Alfentanil—Pruritus—Temozolomide—skin cancer	0.000264	0.00252	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—skin cancer	0.000263	0.00251	CcSEcCtD
Alfentanil—Nausea—Bleomycin—skin cancer	0.000262	0.00251	CcSEcCtD
Alfentanil—Hypertension—Docetaxel—skin cancer	0.000262	0.0025	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—skin cancer	0.000262	0.0025	CcSEcCtD
Alfentanil—Rash—Dactinomycin—skin cancer	0.00026	0.00248	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000257	0.00245	CcSEcCtD
Alfentanil—Hypersensitivity—Fluorouracil—skin cancer	0.000253	0.00242	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—skin cancer	0.00025	0.00239	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—skin cancer	0.000248	0.00237	CcSEcCtD
Alfentanil—Dizziness—Temozolomide—skin cancer	0.000247	0.00235	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—skin cancer	0.000245	0.00234	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—skin cancer	0.000243	0.00232	CcSEcCtD
Alfentanil—Pruritus—Fluorouracil—skin cancer	0.000243	0.00232	CcSEcCtD
Alfentanil—Tachycardia—Docetaxel—skin cancer	0.000242	0.00231	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—skin cancer	0.000241	0.0023	CcSEcCtD
Alfentanil—Vomiting—Temozolomide—skin cancer	0.000237	0.00226	CcSEcCtD
Alfentanil—Rash—Temozolomide—skin cancer	0.000235	0.00224	CcSEcCtD
Alfentanil—Dermatitis—Temozolomide—skin cancer	0.000235	0.00224	CcSEcCtD
Alfentanil—Headache—Temozolomide—skin cancer	0.000234	0.00223	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—skin cancer	0.000232	0.00221	CcSEcCtD
Alfentanil—Dizziness—Fluorouracil—skin cancer	0.000227	0.00217	CcSEcCtD
Alfentanil—Nausea—Temozolomide—skin cancer	0.000221	0.00211	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—skin cancer	0.00022	0.0021	CcSEcCtD
Alfentanil—Vomiting—Fluorouracil—skin cancer	0.000218	0.00208	CcSEcCtD
Alfentanil—Rash—Fluorouracil—skin cancer	0.000217	0.00207	CcSEcCtD
Alfentanil—Dermatitis—Fluorouracil—skin cancer	0.000216	0.00207	CcSEcCtD
Alfentanil—Headache—Fluorouracil—skin cancer	0.000215	0.00205	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—skin cancer	0.000214	0.00204	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—skin cancer	0.000214	0.00204	CcSEcCtD
Alfentanil—Pain—Docetaxel—skin cancer	0.000212	0.00202	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—skin cancer	0.000204	0.00195	CcSEcCtD
Alfentanil—Nausea—Fluorouracil—skin cancer	0.000204	0.00195	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—skin cancer	0.000196	0.00187	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—skin cancer	0.000183	0.00174	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—skin cancer	0.000178	0.0017	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—skin cancer	0.000175	0.00167	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—skin cancer	0.000164	0.00156	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—skin cancer	0.000158	0.0015	CcSEcCtD
Alfentanil—Rash—Docetaxel—skin cancer	0.000156	0.00149	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—skin cancer	0.000156	0.00149	CcSEcCtD
Alfentanil—Headache—Docetaxel—skin cancer	0.000155	0.00148	CcSEcCtD
Alfentanil—Nausea—Docetaxel—skin cancer	0.000147	0.00141	CcSEcCtD
